Celularity, Inc. (CELU)
1.15
-0.10
(-8.00%)
USD |
NASDAQ |
Oct 19, 16:00
1.15
0.00 (0.00%)
After-Hours: 16:14
Celularity Cash from Operations (Annual) : -13.25M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -13.25M |
| December 31, 2024 | -6.401M |
| December 31, 2023 | -38.68M |
| December 31, 2022 | -137.88M |
| Date | Value |
|---|---|
| December 31, 2021 | -110.10M |
| December 31, 2020 | -63.19M |
| December 31, 2019 | -1.098M |
| December 31, 2018 | -0.0005M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Tenax Therapeutics, Inc. | -35.80M |
| Manhattan Scientifics, Inc. | -- |
| Exicure, Inc. | -8.555M |
| Century Therapeutics, Inc. | -103.88M |
| Absci Corp. | -92.92M |